Formulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterization

Abstract Background Floating drug delivery systems have been reported for different active pharmaceutical ingredients as single-unit tablets with gas-generating agents. In this present research, the formulation of floating multiple-unit minitablets of Nimodipine without using gas-generating agent wa...

Full description

Bibliographic Details
Main Authors: M. Panda, M. E. B. Rao, C. N. Patra, J. Panda, K. C. Panigrahi, G. Patro
Format: Article
Language:English
Published: SpringerOpen 2020-02-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://doi.org/10.1186/s43094-020-0021-x
_version_ 1818870909009657856
author M. Panda
M. E. B. Rao
C. N. Patra
J. Panda
K. C. Panigrahi
G. Patro
author_facet M. Panda
M. E. B. Rao
C. N. Patra
J. Panda
K. C. Panigrahi
G. Patro
author_sort M. Panda
collection DOAJ
description Abstract Background Floating drug delivery systems have been reported for different active pharmaceutical ingredients as single-unit tablets with gas-generating agents. In this present research, the formulation of floating multiple-unit minitablets of Nimodipine without using gas-generating agent was attempted with an objective of increased residence time, sustain-release and improved oral bioavailability. Solid dispersion with different ratios (1:0.5, 1:1, 1:1.5, 1:2, 1:2.5) of drug with the lipophilic carrier such as Compritol ATO 888, Gelucire 43/01, G39/01 and Precirol ATO 05 was formulated using melt granulation technique. The adsorbent Sylysia 350 to lipophilic carrier is maintained at 1:1. The granules were compressed into minitablets weighing 15 mg and were filled into a ‘0’ size capsule. Results Differential scanning calorimetry study justified no interaction of the drug with excipients. The formulations which exhibited desirable flow property, floating lag time less than 1 min and floating time of 12 h were further characterized for various post-compression parameters. The optimized single-dose (capsule) of floating multiple-unit minitablets of Nimodipine consisting of 60 mg of drug, 120 mg of G43/01 and 120 mg of Sylysia 350 showed an average of floating lag time within 24.48 s, floating time of 14.32 h and sustained-release up to 12 h. Pharmacokinetic study of the optimized formulation (F9) showed nearly 2.5 times increase in area under the curve with increased residence time in comparison to aqueous suspension of Nimodipine. The stability study revealed no significant change in various parameters before and after storage. Conclusion Hence, gelucire 43/01-based multiple-unit minitablets of Nimodipine can be considered a promising approach for sustaining the drug release with gastric retention for 12 h without using gas-generating agent.
first_indexed 2024-12-19T12:14:30Z
format Article
id doaj.art-d23c6f83b6044a7ebe3a0de867fbca2f
institution Directory Open Access Journal
issn 2314-7253
language English
last_indexed 2024-12-19T12:14:30Z
publishDate 2020-02-01
publisher SpringerOpen
record_format Article
series Future Journal of Pharmaceutical Sciences
spelling doaj.art-d23c6f83b6044a7ebe3a0de867fbca2f2022-12-21T20:22:03ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532020-02-01611910.1186/s43094-020-0021-xFormulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterizationM. Panda0M. E. B. Rao1C. N. Patra2J. Panda3K. C. Panigrahi4G. Patro5Roland Institute of Pharmaceutical Sciences, Berhampur, Biju Patnaik University of TechnologyRoland Institute of Pharmaceutical Sciences, Berhampur, Biju Patnaik University of TechnologyRoland Institute of Pharmaceutical Sciences, Berhampur, Biju Patnaik University of TechnologyRoland Institute of Pharmaceutical Sciences, Berhampur, Biju Patnaik University of TechnologyRoland Institute of Pharmaceutical Sciences, Berhampur, Biju Patnaik University of TechnologyCollege of Pharmaceutical SciencesAbstract Background Floating drug delivery systems have been reported for different active pharmaceutical ingredients as single-unit tablets with gas-generating agents. In this present research, the formulation of floating multiple-unit minitablets of Nimodipine without using gas-generating agent was attempted with an objective of increased residence time, sustain-release and improved oral bioavailability. Solid dispersion with different ratios (1:0.5, 1:1, 1:1.5, 1:2, 1:2.5) of drug with the lipophilic carrier such as Compritol ATO 888, Gelucire 43/01, G39/01 and Precirol ATO 05 was formulated using melt granulation technique. The adsorbent Sylysia 350 to lipophilic carrier is maintained at 1:1. The granules were compressed into minitablets weighing 15 mg and were filled into a ‘0’ size capsule. Results Differential scanning calorimetry study justified no interaction of the drug with excipients. The formulations which exhibited desirable flow property, floating lag time less than 1 min and floating time of 12 h were further characterized for various post-compression parameters. The optimized single-dose (capsule) of floating multiple-unit minitablets of Nimodipine consisting of 60 mg of drug, 120 mg of G43/01 and 120 mg of Sylysia 350 showed an average of floating lag time within 24.48 s, floating time of 14.32 h and sustained-release up to 12 h. Pharmacokinetic study of the optimized formulation (F9) showed nearly 2.5 times increase in area under the curve with increased residence time in comparison to aqueous suspension of Nimodipine. The stability study revealed no significant change in various parameters before and after storage. Conclusion Hence, gelucire 43/01-based multiple-unit minitablets of Nimodipine can be considered a promising approach for sustaining the drug release with gastric retention for 12 h without using gas-generating agent.https://doi.org/10.1186/s43094-020-0021-xFloating multiple unit minitabletsPharmacokinetic studyLipophilic carriers
spellingShingle M. Panda
M. E. B. Rao
C. N. Patra
J. Panda
K. C. Panigrahi
G. Patro
Formulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterization
Future Journal of Pharmaceutical Sciences
Floating multiple unit minitablets
Pharmacokinetic study
Lipophilic carriers
title Formulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterization
title_full Formulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterization
title_fullStr Formulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterization
title_full_unstemmed Formulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterization
title_short Formulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterization
title_sort formulation and development of floating multiple unit minitablets of nimodipine without using a gas generating agent in vitro and in vivo characterization
topic Floating multiple unit minitablets
Pharmacokinetic study
Lipophilic carriers
url https://doi.org/10.1186/s43094-020-0021-x
work_keys_str_mv AT mpanda formulationanddevelopmentoffloatingmultipleunitminitabletsofnimodipinewithoutusingagasgeneratingagentinvitroandinvivocharacterization
AT mebrao formulationanddevelopmentoffloatingmultipleunitminitabletsofnimodipinewithoutusingagasgeneratingagentinvitroandinvivocharacterization
AT cnpatra formulationanddevelopmentoffloatingmultipleunitminitabletsofnimodipinewithoutusingagasgeneratingagentinvitroandinvivocharacterization
AT jpanda formulationanddevelopmentoffloatingmultipleunitminitabletsofnimodipinewithoutusingagasgeneratingagentinvitroandinvivocharacterization
AT kcpanigrahi formulationanddevelopmentoffloatingmultipleunitminitabletsofnimodipinewithoutusingagasgeneratingagentinvitroandinvivocharacterization
AT gpatro formulationanddevelopmentoffloatingmultipleunitminitabletsofnimodipinewithoutusingagasgeneratingagentinvitroandinvivocharacterization